Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: Toward pathophysiological delineation of diabetes mellitus-related osteoarthritis

Osteoarthritis and Cartilage

Volumn 23, Issue 9, 2015, Pages 1513-1522

  Laiguillon, M C ^a   Courties, A ^a,b   Houard, X ^a   Auclair, M ^a   Sautet, A ^b   Capeau, J ^a   Feve B ^a   Berenbaum, F ^a,b   Sellam, J ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Diabetes mellitus; Glucose; Metabolic osteoarthritis; Osteoarthritis; Oxidative stress

Indexed keywords

CYCLOOXYGENASE 2; CYTOCHALASIN B; EPALRESTAT; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; INTERLEUKIN-1BETA (163-171); PEPTIDE FRAGMENT; POLYMER; POLYOL;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; KNEE ARTHROPLASTY; MALE; MOUSE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CARTILAGE; CELL CULTURE; COMPLICATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS);

ANIMALS; CARTILAGE; CELLS, CULTURED; CYCLOOXYGENASE 2; DIABETES MELLITUS, TYPE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOARTHRITIS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; POLYMERS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84940452582     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.04.026     Document Type: Article

References (50)

1. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64(6):1697-1707.
2. Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377(9783):2115-2126.
3. Yusuf E., Ioan-Facsinay A., Bijsterbosch J., Klein-Wieringa I., Kwekkeboom J., Slagboom P.E., et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011, 70(7):1282-1284.
4. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6(11):625-635.
5. Sowers M., Karvonen-Gutierrez C.A., Palmieri-Smith R., Jacobson J.A., Jiang Y., Ashton-Miller J.A. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009, 61(10):1328-1336.
6. Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012, 20(11):1217-1226.
7. Dahaghin S., Bierma-Zeinstra S.M., Koes B.W., Hazes J.M., Pols H.A. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 2007, 66(7):916-920.
8. Sellam J., Berenbaum F. Is osteoarthritis a metabolic disease?. Joint Bone Spine 2013, 80(6):568-573.
9. Schett G., Kleyer A., Perricone C., Sahinbegovic E., Iagnocco A., Zwerina J., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 2013, 36(2):403-409.
10. Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995, 22(6):1118-1123.
11. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis 2011, 70(8):1354-1356.
12. Atayde S.A., Yoshinari N.H., Nascimento D.P., Catanozi S., Andrade P.C., Velosa A.P., et al. Experimental diabetes modulates collagen remodelling of joints in rats. Histol Histopathol 2012, 27(11):1471-1479.
13. Mobasheri A., Neama G., Bell S., Richardson S., Carter S.D. Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9. Cell Biol Int 2002, 26(3):297-300.
14. Mobasheri A., Vannucci S.J., Bondy C.A., Carter S.D., Innes J.F., Arteaga M.F., et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol 2002, 17(4):1239-1267.
15. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414(6865):813-820.
16. Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11(10):747-755.
17. Nelson K.K., Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004, 37(6):768-784.
18. Goodwin W., McCabe D., Sauter E., Reese E., Walter M., Buckwalter J.A., et al. Rotenone prevents impact-induced chondrocyte death. J Orthop Res 2010, 28(8):1057-1063.
19. Vaamonde-Garcia C., Riveiro-Naveira R.R., Valcarcel-Ares M.N., Hermida-Carballo L., Blanco F.J., Lopez-Armada M.J. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum 2012, 64(9):2927-2936.
20. Yu S.M., Kim S.J. Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3K/Akt, p38, and JNK pathways in rabbit articular chondrocytes. Exp Cell Res 2013, 319(18):2822-2834.
21. Murrell G.A., Jang D., Williams R.J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995, 206(1):15-21.
22. Pelletier J.P., Mineau F., Ranger P., Tardif G., Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996, 4(1):77-84.
23. Pelletier J.P., Lascau-Coman V., Jovanovic D., Fernandes J.C., Manning P., Connor J.R., et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999, 26(9):2002-2014.
24. Rosa S.C., Goncalves J., Judas F., Mobasheri A., Lopes C., Mendes A.F. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 2009, 11(3):R80.
25. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29(8):1039-1049.
26. Laiguillon M.C., Houard X., Bougault C., Gosset M., Nourissat G., Sautet A., et al. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther 2014, 16(1):R38.
27. Chauffier K., Laiguillon M.C., Bougault C., Gosset M., Priam S., Salvat C., et al. Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis. Joint Bone Spine 2012, 79(6):604-609.
28. Gosset M., Berenbaum F., Thirion S., Jacques C. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 2008, 3(8):1253-1260.
29. Salvat C., Pigenet A., Humbert L., Berenbaum F., Thirion S. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthritis Cartilage 2005, 13(3):243-249.
30. Shikhman A.R., Brinson D.C., Valbracht J., Lotz M.K. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 2001, 167(12):7001-7008.
31. Windhaber R.A., Wilkins R.J., Meredith D. Functional characterisation of glucose transport in bovine articular chondrocytes. Pflugers Arch 2003, 446(5):572-577.
32. Gabbay K.H. The sorbitol pathway and the complications of diabetes. N Engl J Med 1973, 288(16):831-836.
33. Terashima H., Hama K., Yamamoto R., Tsuboshima M., Kikkawa R., Hatanaka I., et al. Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther 1984, 229(1):226-230.
34. Hotta N. Is there a place for inhibition of transforming growth factor-beta and the polyol pathway in therapy for diabetic retinopathy?. J Diabetes Investig 2010, 1(4):134-136.
35. Yagihashi S., Mizukami H., Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go?. J Diabetes Investig 2011, 2(1):18-32.
36. Hotta N., Sakamoto N., Shigeta Y., Kikkawa R., Goto Y. Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. J Diabetes Complications 1996, 10(3):168-172.
37. Schemmel K.E., Padiyara R.S., D'Souza J.J. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 2010, 24(5):354-360.
38. Hotta N., Kawamori R., Fukuda M., Shigeta Y. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med 2012, 29(12):1529-1533.
39. Blanco F.J., Rego I., Ruiz-Romero C. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 2011, 7(3):161-169.
40. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993, 57(5 Suppl). 715S-724S; discussion 724S-725S.
41. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol 1994, 233:229-240.
42. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87(1):315-424.
43. Abramson S.B. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther 2008, 10(Suppl 2):S2.
44. Cheng X., Ni B., Zhang Z., Liu Q., Wang L., Ding Y., et al. Polyol pathway mediates enhanced degradation of extracellular matrix via p38 MAPK activation in intervertebral disc of diabetic rats. Connect Tissue Res 2013, 54(2):118-122.
45. Capurso C., Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 2012, 57(2-4):91-97.
46. Alvarez-Garcia O., Rogers N.H., Smith R.G., Lotz M.K. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1. Arthritis Rheumatol 2014, 66(7):1779-1788.
47. Kellner K., Schulz M.B., Gopferich A., Blunk T. Insulin in tissue engineering of cartilage: a potential model system for growth factor application. J Drug Target 2001, 9(6):439-448.
48. Claassen H., Schluter M., Schunke M., Kurz B. Influence of 17beta-estradiol and insulin on type II collagen and protein synthesis of articular chondrocytes. Bone 2006, 39(2):310-317.
49. Claassen H., Schicht M., Paulsen F. Impact of sex hormones, insulin, growth factors and peptides on cartilage health and disease. Prog Histochem Cytochem 2011, 45(4):239-293.
50. Rosa S.C., Rufino A.T., Judas F., Tenreiro C., Lopes M.C., Mendes A.F. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthritis Cartilage 2011, 19(6):719-727.